Vanda Pharmaceuticals, Inc. (VNDA)
8.81
-0.48
(-5.17%)
USD |
NASDAQ |
Mar 13, 16:00
8.86
+0.05
(+0.57%)
After-Hours: 20:00
Vanda Pharmaceuticals Shareholders Equity (Quarterly) : 327.19M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 26.54B |
| Gilead Sciences, Inc. | 22.70B |
| Axsome Therapeutics, Inc. | 88.30M |
| Gossamer Bio, Inc. | -82.33M |
| Arcellx, Inc. | 402.35M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 488.95M |
| Total Liabilities (Quarterly) | 161.76M |
| Debt to Equity Ratio | 0.0386 |
| Current Ratio | 2.392 |
| Net Debt Paydown Yield | -0.18% |